Funding sources: KaryoLite™ BoBs™ reagents for this study were supplied by PerkinElmer, Wallac, Turku, Finland.
Application of a new molecular technique for the genetic evaluation of products of conception
Version of Record online: 20 NOV 2012
© 2012 John Wiley & Sons, Ltd.
Volume 33, Issue 1, pages 32–41, January 2013
How to Cite
Grati, F. R., Gomes, D. M., Ganesamoorthy, D., Marcato, L., De Toffol, S., Blondeel, E., Malvestiti, F., Loeuillet, L., Ruggeri, A. M., Wainer, R., Maggi, F., Aboura, A., Dupont, C., Tabet, A. C., Guimiot, F., Slater, H. R., Simoni, G. and Vialard, F. (2013), Application of a new molecular technique for the genetic evaluation of products of conception. Prenat. Diagn., 33: 32–41. doi: 10.1002/pd.4004
Conflicts of interest: Francesca R. Grati, Livia Marcato, Simona De Toffol, Francesca Malvestiti, Anna Maria Ruggeri, Federico Maggi and Giuseppe Simoni are full-time employees of the TOMA Advanced Biomedical Assays S.p.A. and declare no conflict of interest. Denise Molina Gomes, Laurence Loeuillet, Robert Wainer, Eleonore Blondeel and François Vialard are employees of the Hospital CHI Poissy St Germain and declare no conflict of interest. Devika Ganesamoorthy and Howard R. Slater are employees of the Royal Children's Hospital and declare no conflict of interest. Azzedine Aboura, Celine Dupont, Anne Claude Tabet and Fabien Guimiot are employees of the Hôpital Robert Debré and declare no conflict of interest.
- Issue online: 7 JAN 2013
- Version of Record online: 20 NOV 2012
Supporting information may be found in the online version of this article.
|pd_4004_supplementary_material.doc||Word document||514K||Supporting information|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.